Therapeutics Related News

Intellia Therapeutics Announces Patent for CRISPR/Cas Genome Editing in China

CAMBRIDGE, Mass., June 19, 2017 (GLOBE NEWSWIRE) — Intellia Therapeutics (NASDAQ: NTLA), a leading genome editing company focused on the development of potentially curative therapeutics using CRISPR technology, today announced that China’s State Intellectual Property Office (“SIPO”) has indicated that [...]

By | June 20th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

CRISPR Therapeutics Announces Patent for CRISPR/Cas Genome Editing in China

BASEL, Switzerland, June 19, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, announced that China’s State Intellectual Property Office (“SIPO”) has granted a patent broadly covering CRISPR’s in-licensed gene [...]

By | June 20th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Eligo Bioscience Awarded as Technology Pioneer by World Economic Forum

Paris, June 14, 2017 – Eligo Bioscience, the Paris-based start-up that seeks to enable precise engineering of the microbiome, was chosen among hundreds of candidates as one of the World Economic Forum’s “technology pioneers,” a selection of the world’s most [...]

By | June 14th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Intellia Therapeutics and San Raffaele University and Research Hospital to Combine CRISPR/Cas9 Genome Editing with Enhanced Cell Therapies to Fight Cancer

CAMBRIDGE, Mass., and MILAN, Italy, June 6, 2017 (GLOBEWIRE) – Intellia Therapeutics (NASDAQ:NTLA), a leading genome editing company, and San Raffaele University and Research Hospital, a leading scientific institution, have entered into a three-year research collaboration, option and license agreement [...]

By | June 7th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Synlogic Meets First Discovery Milestone in Partnership with AbbVie

June 07, 2017 08:15 AM Eastern Daylight Time  CAMBRIDGE, Mass.--(BUSINESS WIRE)--Synlogic™ has completed the first phase of its ongoing collaboration with AbbVie. During this first discovery phase of the collaboration Synlogic has identified Synthetic Biotic™ leads for the treatment of [...]

By | June 7th, 2017|BioPharma & Healthcare, News, Therapeutics|

Cell Design Labs Announces Issuance of Broad Patent for Chimeric Notch (synNotch™) Receptor to Treat Cancer and Other Diseases

EMERYVILLE, Calif., June 07, 2017 (GLOBE NEWSWIRE) -- Cell Design Labs, Inc. today announced the issuance of U.S. Patent No. 9,670,281, entitled “Binding-triggered transcriptional switches and the methods of use thereof.” This patent, issued to UC San Francisco (UCSF) and [...]

By | June 7th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|